26.11.2024, 14:21
The discontinuation of Tadalafil Femalefil likely stems from a combination of factors, including insufficient clinical evidence for its effectiveness in women, regulatory hurdles, and the availability of other approved treatments for female sexual dysfunction. The treatment of female sexual health is a complex issue, and many women may not find relief from medications like Tadalafil, which was originally developed for men. Until there is more robust evidence and approval, it's unlikely that similar products will gain widespread acceptance.